CD4 and type 2 diabetes mellitus: Considering that T2D affect antigen presentation by macrophages, activation of monocytes, and chemoattraction of immune cells to lung during infection, BCGΔBCG1419c provides an opportunity to ascertain the role of cells other than macrophages and T CD4+ lymphocytes in protection conferred by this vaccine candidate, despite T2D.